BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 8 of about 8   

Articles published

BMTI 0.0000
price chart
Aethlon Medical Receives Notice of DARPA Contract Renewal
22, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that the Defense Advanced Research ...
Breaking Biodefense News: Aethlon Medical (NASDAQ:OTCQB: AEMD ...  InvestorIdeas.com (press release)
Related articles »  
Global Growth Factors (Blood and Tissue) Industry
Alseres Pharmaceuticals, Inc. Amgen, Inc. Bayer HealthCare Pharmaceuticals, Inc. Biogen Idec Inc. BioMimetic Therapeutics, Inc. I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS. Study Reliability and Reporting Limitations I-1. Disclaimers I-2.
Related articles »